- Poster presentation
- Published:
Hyperglycemia and changes in osmolarity lead to an increase in IL-6 and IL-1β cytokine production of human peripheral blood mononuclear cells in vitro
Critical Care volume 11, Article number: P122 (2007)
Introduction
Acute hyperglycemia and insulin resistance are characteristics of metabolic and endocrine imbalances of critically ill patients and are subject to a substantial inflammatory response that is partly mediated by cytokines produced by peripheral blood mononuclear cells (PBMC). Treatment with intensive insulin therapy to keep patients normoglycemic has been shown to reduce inflammatory responses. It is unclear whether hyper-glycemia, insulin or osmolarity changes exert direct effects on proinflammatory cytokines. We investigated the direct effects of these substances on cytokine production of PBMC in vitro.
Methods
PBMC were isolated from peripheral blood of 10 healthy volunteers via Ficoll gradient. Cells were incubated for 3 hours at 37°C with/without low/high concentrations of glucose, mannitol, urea, insulin and stimulated with 0.5 ng/ml LPS. After 24 hours, concentrations of IL-6 and IL-1β were measured with an ELISA method.
Results
Increasing concentrations of glucose, mannitol and urea resulted in a significant increase of IL-6 and IL-1β cytokine production. Insulin had no effect (Table 1).
Conclusion
High concentrations of glucose, mannitol and urea lead to a significant increase in IL-6 and IL-1β cytokine production by PBMC in vitro. The most profound effect was seen with hyperglycemia. Besides hyperglycemia, also uremia and high osmolarity seem to augment inflammation. Insulin could not reverse the increase in inflammation. These findings may be relevant in explaining the beneficial effects of normoglycemia on the inflammatory response in critically ill patients.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Otto, N., Schindler, R., Frei, U. et al. Hyperglycemia and changes in osmolarity lead to an increase in IL-6 and IL-1β cytokine production of human peripheral blood mononuclear cells in vitro. Crit Care 11 (Suppl 2), P122 (2007). https://doi.org/10.1186/cc5282
Published:
DOI: https://doi.org/10.1186/cc5282